Pacira Pharmaceuticals reported $65M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 6.82M 516K
Aerie Pharmaceuticals AERI:US $ 28.15M 3.38M
Amerisourcebergen ABC:US $ 1.21B 8.91M
Astellas Pharma 4503:JP 153.4B 10.98B
Bristol Myers Squibb BMY:US $ 1.78B 46M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Coherus Biosciences CHRS:US $ 51.28M 2.52M
Depomed DEPO:US $ 10.54M 105K
Endo International Ordinary Shares ENDP:US 180.83M 45.18M
Heron Therapeutics HRTX:US $ 32.12M 836K
Horizon Pharma HZNP:US 398.22M 25.49M
Ironwood Pharmaceuticals IRWD:US $ 30.12M 1.26M
JAZZ PHA JAZZ:US 325.67M 16.86M
Johnson & Johnson JNJ:US $ 6.23B 288M
Lannett LCI:US $ 25.76M 8.18M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Omeros OMER:US $ 13.92M 2.96M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Perrigo Ordinary Shares PRGO:US 338.1M 55.8M
Pfizer PFE:US $ 3.2B 506M
Revance Therapeutics RVNC:US $ 46.19M 2.21M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Teva Pharmaceutical TEVA:IT 849M 30M
Xeris Pharmaceuticals Inc XERS:US $ 32.98M 5.67M
Xoma XOMA:US $ 5.71M 594K
Zoetis ZTS:US $ 529M 64M